01093.HK
CSPC Pharmaceutical Group Limited
HKSE · Healthcare · Drug Manufacturers - General · CN
HKD 8.93
+0.90%Year over year
Reported trailing growth
- Revenue
- +18.8%
- EBITDA
- +57.0%
- EBIT
- +104.7%
- EPS
- +97.0%
- Free cash flow
- -47.8%
- Operating cash flow
- -57.6%
Forward estimates
Based on analyst estimates
- Revenue
- +2.0%
- EBITDA
- -15.0%
- EPS
- -23.9%
Three-year CAGR
- Revenue
- -7.1%
- EBITDA
- -16.0%
- EBIT
- -17.7%
- Net income
- -15.3%
- EPS
- -14.1%
- Free cash flow
- -15.6%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026